Edwards Lifesciences Corp
SWB:EWL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Edwards Lifesciences Corp
SWB:EWL
|
US |
|
Anika Therapeutics Inc
NASDAQ:ANIK
|
US |
|
Quebecor Inc
F:QB3
|
CA |
|
A
|
Airbus SE
XHAM:AIR
|
NL |
|
J
|
Jones Lang LaSalle Inc
F:4J2
|
US |
|
Chubb Limited
NYSE:CB
|
CH |
|
Eni SpA
NYSE:E
|
IT |
|
L
|
Las Vegas Sands Corp
F:LCR
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EWL's stock price target?
Price Target
88.43
EUR
According to Wall Street analysts, the average 1-year price target for 
EWL is 88.43 EUR with a low forecast of 73.69 EUR and a high forecast of 99.14 EUR.
What is the Revenue forecast for Edwards Lifesciences Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 10%.
What is the Gross Profit forecast for Edwards Lifesciences Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 5 years is 10%.
What is the Operating Income forecast for Edwards Lifesciences Corp?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is 13%.
What is the Pre-Tax Income forecast for Edwards Lifesciences Corp?
Projected CAGR
28%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 28%.
What is the Net Income forecast for Edwards Lifesciences Corp?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 5 years is 20%.